AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Tomorrow is the Ex-Dividend Date of Abrdn Life Sciences Investors, the Company Would Pay a Dividend of $0.43
ByAinvest
Wednesday, May 21, 2025 6:30 am ET1min read
Tomorrow(5/22/2025) is the ex-dividend date of Abrdn Life Sciences Investors(HQL), Abrdn Life Sciences Investors would pay a dividend of $0.43 on 6/30/2025.
| Code | Company | Dividend Per Share | Declaration Date | EX-Dividend Date | Holder-of-Record date | Payment Date | Special Dividend |
|---|---|---|---|---|---|---|---|
| HQL | Abrdn Life Sciences Investors | $0.43 | 2025-05-09 | 2025-05-22 | 2025-05-22 | 2025-06-30 | No |
| HQL | Abrdn Life Sciences Investors | $0.47 | 2025-02-11 | 2025-02-21 | 2025-02-21 | 2025-03-31 | No |
| HQL | Abrdn Life Sciences Investors | $0.5 | 2024-11-11 | 2024-11-21 | 2024-11-21 | 2025-01-10 | No |
| HQL | Abrdn Life Sciences Investors | $0.49 | 2024-08-09 | 2024-08-23 | 2024-08-23 | 2024-09-30 | No |
| HQL | Abrdn Life Sciences Investors | $0.48 | 2024-05-09 | 2024-05-22 | 2024-05-23 | 2024-06-28 | No |
| HQL | Abrdn Life Sciences Investors | $0.31 | 2022-11-15 | 2022-11-23 | 2022-11-25 | 2022-12-30 | No |
*The ex-dividend date is the trading date on and after which the dividend is not owed to a new buyer of the stock. The ex-dividend date is one business day before the date of record.
*The date of record is the day on which the company checks its records to identify shareholders of the company.
[Recent Performance]
The latest share price of Abrdn Life Sciences Investors was $12.72, up 4.86% in the last 5 trading days.
[Company Profile]
Abrdn Life Sciences Investors is a Massachusetts business trust formed on February 20, 1992, and registered under the Investment Company Act of 1940 as a non-diversified closed-end management investment company. The Fund commenced operations on May 8, 1992. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of life sciences companies.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet